Reply Indian Pediatrics 2002; 39:703-704 |
Imipenem |
Thanks for reading the article with interest and giving the opportunities to provide further clarifications:
Manju Salaria Department of Pediatrics, Advanced Pediatric Center, Post-graduate Institute of Medical Education and Research, Chandigarh 160 012, India.
|
References |
1. Cornaglia G, Mazzariol A, Hauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem resistant Pseudomonas aeruginosa producing VIM-1, a Novel Transferable Metallo-B-Lactamase. Clinic Inf Dis 2000; 31: 1119-1125. 2. Oral R, Akisu M, Kutursay N, Vardar F, Tansug N. Neonatal Klebsiella pneumonia sepsis and Imipenem - cilastatin. Indian J Pediatr 1998; 65: 121-129. 3. Alpert G, Dagan R, Connor E, Campos JM, Bloh M, Powell KR et al. Imipenem/Cilastatin for the treatment of infections in hospitalized children. Am J Dis Child 1985; 139: 1153-1156. 4. Klugman KP, Dagan R. Carbapenem treatment of meningitis. Scand J Infect Dis Suppl 1995; 96: 45-48. 5. Haimi Cohen Y, Amir J, Weinstock A, Varsano I. The use of imipenem-cilastatin in neontal meningitis caused by citrobacter diversus. Acta Pediatr 1993; 82: 530-553.
|